Arteris director trust sells 90,279 AIP shares

Arteris, Inc. director-related entity activity shows the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust selling a total of 90,279 shares of common stock in open-market transactions.

Rhea-AI Filing Summary

Arteris, Inc. director-related entity activity shows the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust selling a total of 90,279 shares of common stock in open-market transactions. These sales occurred on February 25–27, 2026 at weighted average prices around $17 per share under a pre-arranged Rule 10b5-1 trading plan.

After these indirect sales, the trust held 499,721 shares, while a separate direct holding for the reporting person stood at 20,839 shares of Arteris common stock as of February 25, 2026.

Insider Trade Summary

Net Seller: 90,279 shares

Net Sell 4 txns

Insider RAZA SAIYED ATIQ

Role Director

Sold 90,279 shs ($1.55M)

Type	Security	Shares	Price	Value
Sale	Common Stock	11,762	$17.0079	$200K
Sale	Common Stock	73,610	$17.1416	$1.26M
Sale	Common Stock	4,907	$17.0001	$83K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 499,721 shares (Indirect, Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012); Common Stock — 20,839 shares (Direct)

Footnotes (5)

1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.
2. F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.01 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.
4. F4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.25 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. F5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.05 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

FAQ

What insider transaction did Arteris (AIP) report on this Form 4?

The filing reports open-market sales of 90,279 Arteris common shares by a revocable trust associated with director Saiyed Atiq Raza. These transactions occurred over three days at weighted average prices near $17 per share.

Who executed the recent Arteris (AIP) share sales disclosed in the filing?

The sales were executed by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which Raza serves as trustee. The transactions are reported as indirect ownership activity related to his role with Arteris, Inc.

How many Arteris (AIP) shares did the trust sell and at what prices?

The trust sold 90,279 Arteris common shares in total. Reported weighted average sale prices were approximately $17.00–$17.25 per share, with specific ranges detailed in footnotes for each trading day.

Was the Arteris (AIP) insider selling done under a 10b5-1 trading plan?

Yes. A footnote states the transactions were made under a Rule 10b5-1 trading plan adopted on November 7, 2025. Such pre-arranged plans automate trades according to preset instructions rather than discretionary timing.

How many Arteris (AIP) shares did the trust hold after the reported sales?

Following the reported sales, the revocable trust held 499,721 shares of Arteris common stock. Separately, the reporting person’s direct holding was 20,839 shares as of the date shown for that ownership line.

What is the role of the reporting person in the Arteris (AIP) transactions?

The reporting person, director Saiyed Atiq Raza, serves as trustee of the revocable trust that holds the indirectly owned shares. The Form 4 reflects his indirect ownership and the trust’s open-market sale activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 05:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RAZA SAIYED ATIQ

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		S(1)		4,907	D	$17.0001(2)	585,093	I	Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012(3)
Common Stock	02/26/2026		S(1)		73,610	D	$17.1416(4)	511,483	I	Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012(3)
Common Stock	02/27/2026		S(1)		11,762	D	$17.0079(5)	499,721	I	Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012(3)
Common Stock								20,839	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.01 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.

4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.25 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.05 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for S. Atiq Raza	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.